Home » Case Studies » Early Diagnosis with Patient-Finding Analytics in Immunology
Early Diagnosis with Patient-Finding Analytics in Immunology
analytics project BACKGROUND
![questions icon](https://www.81qd.com/wp-content/uploads/questions-icon.png)
Situation
Immunology product on the market for 3 years with growth stagnating
Crowded marketplace with 5 competitors
Disease is not optimally managed
![challenges icon](https://www.81qd.com/wp-content/uploads/challenges-icon.png)
Challenges
Increase disease diagnosis rates by 10%
Accelerate product adoption with the appropriate patient types
Improve efficiency and effectiveness of HCP and patient promotion
![Data Analysis Icon](https://www.81qd.com/wp-content/uploads/situation-icon.png)
Questions
What is the treatment journey for our target patients?
Which clinicians are currently managing undiagnosed patients?
How do we drive improved diagnosis rates?
Patient finding Approach
Analyze | Assess | Action | |
---|---|---|---|
KEY BUSINESS QUESTION | What is the treatment journey for our target patients? | Which clinicians are currently managing undiagnosed patients? |
How do we drive improved diagnosis rates?
|
81qd APPROACH |
Mapped clinical journey to understand patient flow and treatment patterns
Conducted Orion analytics to identify undiagnosed patients |
Mapped undiagnosed and diagnosed patients to providers currently managing them
Prioritized providers based on undiagnosed patient volume, specialty, as well as frequency and recency of interaction |
Leveraged insights from Plexus analytics to connect providers currently managing undiagnosed patients with the clinical leaders in their networks who were experts in diagnosing the disease |
Undiagnosed Patient analytics project Outcome
Expanded Commercial Potential
- Found more than 100K undiagnosed patients who were being seen by at least 1 physician
- Uncovered target patients “hiding in plain sight” (ie, being treated by targets for other conditions)
Improved HCP Promotional Effectiveness
- Segmented HCPs based on patient volume (diagnosed and undiagnosed), as well as diagnosis rates
- Drove HCP awareness and education by equipping MSLs with a suite of unbranded tools
- Collaborated with community through ongoing educational partnerships
Revolutionized Patient Engagement Paradigm
- Changed paradigm by revealing that 58% of undiagnosed patients were female vs expected 75% male
- Customized content based on actual patient profiles
- Launched breakthrough disease education campaign targeting undiagnosed patients